The Clinical Utility of Precision-Guided Dosing for Adalimumab Therapy Optimization in Inflammatory Bowel Disease: A Clinical Experience Program

By sjmartinez • April 27, 2025

Hanauer SB, Torres EA, Aragon-Han P, Chapman JC, Swaminath AC, Arai R, Butnariu M, Lee TC, Rabizadeh S, Check M, Barrett TA, Hashash JG, Meister T, Yen EF, Kinnucan J, Stein DJ, Ziring D, Shaposhnikov R, Sinh P, Qazi TM, Yarur AJ, Monzur F, Dervieux T, Abraham BP. The Clinical Utility of Precision-Guided Dosing for Adalimumab Therapy Optimization in Inflammatory Bowel Disease: A Clinical Experience Program. Pharmaceutics. 2025 Mar 27;17(4):428. doi: 10.3390/pharmaceutics17040428. PMID: 40284422; PMCID: PMC12030419.

Tags: adalimumab, Cedars Sinai DoM, clearance, Digestive Diseases, dose optimization, inflammatory bowel disease, pharmacokinetics; precision medicine, precision-guided dosing, Publications, real-world data, therapeutic drug monitoring

The Equivalents Are Coming! Developing a Shared Nomenclature for Radiopharmaceutical Therapy of Neuroendocrine Tumors, Prostate Cancer, and Beyond

Chauhan A, Hendifar AE, El-Haddad G, Soares HP, Herrmann K. The Equivalents Are Coming! Developing a Shared Nomenclature for Radiopharmaceutical Therapy of Neuroendocrine Tumors, Prostate[...]

A 20-minute, free-running, whole-heart cardiac MRI to image myocardial injury following reperfused myocardial infarction: demonstration in a large animal model

Zhang X, Yang HJ, Huang Y, Yoosefian G, Vora K, Youssef K, Wilk B, Christodoulou AG, Li D, Sharif B, Prato FS, Kumar A, Dharmakumar[...]

A contemporary approach to diagnosis and treatment of right heart thrombus associated with pulmonary embolism

Matusov Y, Dohad S, Megna D Jr, Ranade M, Yaqoob M, Vintch JRE. A contemporary approach to diagnosis and treatment of right heart thrombus associated[...]